Chetan Raina, CFA Chief Executive Officer
15+ years of finance, investing and operations experience. Formerly Managing Director at Good Hill Partners LP, a hedge fund in Westport, CT.
Carl Laflamme, PhD Chief Science Officer A molecular biologist. Authored key eLife paper outlining antibody characterization procedure.
Peter S. McPherson, PhD Scientific Advisor Distinguished James McGill Professor at The Montreal Neurological Institute. Lead Academic on key technology paper.
Thomas M. Durcan, PhD Scientific Advisor
Assistant Professor at The Montreal Neurological Institute. Lead Academic on key technology paper.
Riham Ayoubi, PhD Postdoctoral Fellow Expert biochemist. Western blot and immunoprecipitation expert trained by Drs. Annie Anger (Université de Montréal) and Peter McPherson (McGill).
Walaa Alshafie, PhD Postdoctoral Fellow Imaging specialist. Trained by Drs. Thomas Stroh and Peter McPherson at the Montreal Neurological Institute (McGill). Walaa is optimizing the automation of the antibody screening procedure by immunofluorescence.
Maryam Fotouhi Research Assistant Worked for 15 years in the laboratory of Peter McPherson. Maryam has been involved in training dozens of students and postdoctoral fellows for various antibody-based experiments.
Kathleen Southern Summer Student Kathleen is a undergraduate Biochemistry student at McGill. She is studying trends in antibody usage and the response in the literature to the publication of characterization data.
Aled Edwards, PhD Board Chair
CEO of the Structural Genomics Consortium.